Authors:
BONNET R
SOUWEINE B
GAUTHIER G
RICH C
LIVRELLI V
SIROT J
JOLY B
FORESTIER C
Citation: R. Bonnet et al., NON-O157-H7 STX2-PRODUCING ESCHERICHIA-COLI STRAINS ASSOCIATED WITH SPORADIC CASES OF HEMOLYTIC-UREMIC SYNDROME IN ADULTS, Journal of clinical microbiology, 36(6), 1998, pp. 1777-1780
Authors:
SIROT D
LABIA R
POUEDRAS P
CHANALCLARIS C
CERCEAU C
SIROT J
Citation: D. Sirot et al., INHIBITOR-RESISTANT OXY-2-DERIVED BETA-LACTAMASE PRODUCED BY KLEBSIELLA-OXYTOCA, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2184-2187
Authors:
BRET L
CHANALCLARIS C
SIROT D
CHAIBI EB
LABIA R
SIROT J
Citation: L. Bret et al., CHROMOSOMALLY ENCODED AMPC-TYPE BETA-LACTAMASE IN A CLINICAL ISOLATE OF PROTEUS-MIRABILIS, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1110-1114
Authors:
SIROT D
RECULE C
CHAIBI EB
BRET L
CROIZE J
CHANALCLARIS C
LABIA R
SIROT J
Citation: D. Sirot et al., A COMPLEX MUTANT OF TEM-1 BETA-LACTAMASE WITH MUTATIONS ENCOUNTERED IN BOTH IRT-4 AND EXTENDED-SPECTRUM TEM-15, PRODUCED BY AN ESCHERICHIA-COLI CLINICAL ISOLATE, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1322-1325
Authors:
CHANALCLARIS C
SIROT D
BRET L
CHATRON P
LABIA R
SIROT J
Citation: C. Chanalclaris et al., NOVEL EXTENDED-SPECTRUM TEM-TYPE BETA-LACTAMASE FROM AN ESCHERICHIA-COLI ISOLATE RESISTANT TO CEFTAZIDIME AND SUSCEPTIBLE TO CEPHALOTHIN, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 715-716
Authors:
BRET L
CHAIBI EB
CHANALCLARIS C
SIROT D
LABIA R
SIROT J
Citation: L. Bret et al., INHIBITOR-RESISTANT TEM (IRT) BETA-LACTAMASES WITH DIFFERENT SUBSTITUTIONS AT POSITION-244, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2547-2549
Authors:
KOECK JL
CAVALLO JD
FABRE R
MEYRAN M
ROUE R
AUBERTIN J
LACUT J
BEBEAR C
DUPON M
MORLAT P
GARRE M
CHASTEL C
GARO B
TANDE D
REY M
BEYTOUT J
SIROT J
LAURICHESSE H
MARTIN D
PORTIER H
KAZMIERZACK A
KISTERMAN JP
DUEZ JM
MICOUD M
STAHL JP
LENOC P
BOSSERAY A
BEAUCAIRE G
MOUTON Y
BEUSCART C
LEROY O
CAILLAUX M
PEYRAMOND D
TIGAUD S
JAMBON F
BERTHELEMY C
DESPAUX E
CANTON P
GERARD A
BURDIN JC
MAY T
LION D
RAFFI F
BLANLOEIL Y
CAILLON J
DELLAMONICA P
LEFEBVRE JC
BERNARD E
ELBAZE P
DEBORD T
BECQGIRAUDON B
ROBLOT F
GRIGNON B
REMY G
CHIPPAUX C
JAUSSAUD R
VERNET V
CARTIER P
AVRIL JL
BEURRIER P
HUMBERT G
LEMELAND JF
CARON F
CRISTMANN D
MONTEIL H
CHOUTET P
BESNIER JM
Citation: Jl. Koeck et al., ANTIBIOTIC SUSCEPTIBILITY OF GRAM-NEGATIV E BACTERIA ISOLATED FROM SEVERE INFECTIONS IN 1992 - RESULTS OF A FRENCH MULTICENTER STUDY, La Presse medicale, 25(30), 1996, pp. 1363-1366
Citation: L. Bret et al., CHARACTERIZATION OF AN INHIBITOR-RESISTANT ENZYME IRT-2 DERIVED FROM TEM-2 BETA-LACTAMASE PRODUCED BY PROTEUS-MIRABILIS STRAINS, Journal of antimicrobial chemotherapy, 38(2), 1996, pp. 183-191
Authors:
CHANAL C
SIROT D
ROMASZKO JP
BRET L
SIROT J
Citation: C. Chanal et al., SURVEY OF PREVALENCE OF EXTENDED-SPECTRUM BETA-LACTAMASES AMONG ENTEROBACTERIACEAE, Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 127-132
Authors:
FORESTIER C
MEYER M
FAVREBONTE S
RICH C
MALPUECH G
LEBOUGUENEC C
SIROT J
JOLY B
DECHAMPS C
Citation: C. Forestier et al., ENTEROADHERENT ESCHERICHIA-COLI AND DIARRHEA IN CHILDREN - A PROSPECTIVE CASE-CONTROL STUDY, Journal of clinical microbiology, 34(12), 1996, pp. 2897-2903
Authors:
THABAUT A
AVRIL JL
BEBEAR C
BERGOGNEBEREZIN E
BOUCOT I
CHICHE D
CLUZEL R
JARLIER V
GROSSET J
LEMELAND JF
MEYRAN M
MONTEIL H
MOREL C
NICOLAS MH
PHILIPPON A
REVERDY ME
SIROT J
Citation: A. Thabaut et al., EVOLUTION OF SUSCEPTIBILITY TO CEFTAZIDIM E AND 3 OTHER BETA-LACTAM AGENTS AGAINST GRAM-NEGATIVE BACILLI IN-HOSPITAL BETWEEN 1989 AND 1993, Medecine et maladies infectieuses, 25, 1995, pp. 6-19
Authors:
ROMASZKO JP
BRET L
HENQUELL C
SIROT D
CHANAL C
SIROT J
Citation: Jp. Romaszko et al., DETECTION OF INHIBITOR-RESISTANT TEM BETA -LACTAMASES BY DISK DIFFUSION METHOD, Pathologie et biologie, 43(4), 1995, pp. 306-309
Authors:
CHARDON H
FARZANEH S
LABIA R
JARLIER V
NICOLAS MH
PAUL G
POYART C
SIROT D
SIROT J
Citation: H. Chardon et al., ANALYSIS OF BETA-LACTAMASES PRODUCED BY CEPHALOTHIN-SUSCEPTIBLE ESCHERICHIA-COLI CLINICAL ISOLATES RESISTANT TO CO-AMOXICLAV AND TICARCILLIN-CLAVULANIC ACID, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 267-269
Authors:
HENQUELL C
CHANAL C
SIROT D
LABIA R
SIROT J
Citation: C. Henquell et al., MOLECULAR CHARACTERIZATION OF 9 DIFFERENT TYPES OF MUTANTS AMONG 107 INHIBITOR-RESISTANT TEM BETA-LACTAMASES FROM CLINICAL ISOLATES OF ESCHERICHIA-COLI, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 427-430
Authors:
LEMOZY J
SIROT D
CHANAL C
HUC C
LABIA R
DABERNAT H
SIROT J
Citation: J. Lemozy et al., FIRST CHARACTERIZATION OF INHIBITOR-RESISTANT TEM (IRT) BETA-LACTAMASES IN KLEBSIELLA-PNEUMONIAE STRAINS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2580-2582
Authors:
SOUSSY CJ
CLUZEL R
COURVALIN P
ACAR JF
BERGOGNEBEREZIN E
CHABBERT Y
COURTIEU A
DABERNAT H
DRUGEON H
DUVAL J
FLANDROIS JP
FLEURETTE J
GOLDSTEIN F
MEYRAN M
MOREL C
PHILIPPON A
SIROT J
THABAUT A
VERON M
Citation: Cj. Soussy et al., DEFINITION AND DETERMINATION OF IN-VITRO ANTIBIOTIC SUSCEPTIBILITY BREAKPOINTS FOR BACTERIA IN FRANCE, European journal of clinical microbiology & infectious diseases, 13(3), 1994, pp. 238-246
Authors:
VAN JCN
COLLET L
CHARDON H
JARLIER V
POYARTSALMERON C
SIROT D
SIROT J
LABIA R
Citation: Jcn. Van et al., ACTIVITY OF AUGMENTIN(R) AGAINST 998 STRA INS OF ESCHERICHIA-COLI ISOLATED IN 4 FRENCH HOSPITALS IN 1992, Medecine et maladies infectieuses, 24(6-7), 1994, pp. 765-773
Authors:
LAURICHESSE H
HENQUELL C
MARCUCILLI A
BIELSA C
SIROT D
BEYTOUT J
SIROT J
Citation: H. Laurichesse et al., ANTIBIOTIC-RESISTANCE OF ESCHERICHIA-COLI IN AUVERGNE - EPIDEMIOLOGICDATA, Medecine et maladies infectieuses, 24, 1994, pp. 526-529
Authors:
HENQUELL C
SIROT D
CHANAL C
DECHAMPS C
CHATRON P
LAFEUILLE B
TEXIER P
SIROT J
CLUZEL R
Citation: C. Henquell et al., FREQUENCY OF INHIBITOR-RESISTANT TEM BETA-LACTAMASES IN ESCHERICHIA-COLI ISOLATES FROM URINARY-TRACT INFECTIONS IN FRANCE, Journal of antimicrobial chemotherapy, 34(5), 1994, pp. 707-714
Authors:
SIROT D
CHANAL C
HENQUELL C
LABIA R
SIROT J
CLUZEL R
Citation: D. Sirot et al., CLINICAL ISOLATES OF ESCHERICHIA-COLI PRODUCING MULTIPLE TEM MUTANTS RESISTANT TO BETA-LACTAMASE INHIBITORS, Journal of antimicrobial chemotherapy, 33(6), 1994, pp. 1117-1126
Authors:
DECHAMPS C
FRANCHINEAU P
GOURGAND JM
LORIETTE Y
GAULME J
SIROT J
Citation: C. Dechamps et al., CLINICAL AND BACTERIOLOGICAL SURVEY AFTER CHANGE IN AMINOGLYCOSIDE TREATMENT TO CONTROL AN EPIDEMIC OF ENTEROBACTER-CLOACAE, The Journal of hospital infection, 28(3), 1994, pp. 219-229
Authors:
CHANAL C
SIROT D
MALAURE H
POUPART MC
SIROT J
Citation: C. Chanal et al., SEQUENCES OF CAZ-3 AND CTX-2 EXTENDED-SPECTRUM BETA-LACTAMASE GENES, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2452-2453
Authors:
ACAR J
BERGOGNEBEREZIN E
BROGARD JM
CHABBERT Y
CLUZEL R
COURVALIN P
DABERNAT H
DRUGEON H
DUBREUIL L
DUVAL J
FLANDROIS JP
FLEURETTE J
GOLDSTEIN F
MEYRAN M
MOREL C
PHILIPPON A
SIROT J
SOUSSY CJ
THABAUT A
VERON M
Citation: J. Acar et al., 1993 STATEMENT OF THE ANTIBIOGRAM COMMITT EE OF THE FRENCH SOCIETY FOR MICROBIOLOGY, Pathologie et biologie, 41(8), 1993, pp. 741-748